Kaitlyn Brosco

Kaitlyn Brosco is an experienced professional in investor relations and corporate communications, currently serving as Associate Director of Investor Relations and Corporate Communications at Iovance Biotherapeutics, Inc. since May 2025. Previously, Kaitlyn held the position of Director of Investor Relations at Vicarious Surgical Inc. from June 2022 to April 2025. Additional roles include Senior Manager of Investor Relations & Communications at Esperion from August 2020 to April 2022, and Assistant Vice President at The Ruth Group from February 2018 to August 2020, where Kaitlyn also served as a Senior Analyst. Prior experience includes working as a Research Associate in Capital Markets at Autonomous Research and as an Investor Relations & Global Business Development Associate at Allergan. Kaitlyn holds a Bachelor of Business Administration in Finance & Computer Applications from the University of Notre Dame, earned in 2014.